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Somatostatin (SS) is a widely distributed polypep-
tide that exerts inhibitory effects on hormone se-
cretion and cell proliferation by interacting with
five different receptors (SST1-SST5). -Arrestins
have been implicated in regulating SST internaliza-
tion, but the structural domains mediating this ef-
fect are largely unknown. The aim of this study was
to characterize the intracellular mechanisms re-
sponsible for internalization of human SST5 in the
rat pituitary cell line GH3 and to identify the SST5
structural domains involved in this process. To this
purpose we evaluated, by fluorescence micros-
copy and biochemical assay, the ability of wild-
type, progressive C-terminal truncated and third
cytoplasmatic loop mutants SST5-DsRed to asso-
ciate with -arrestin-enhanced green fluorescent
protein and to internalize under SS28 stimulation.
The truncated mutants were comparable to the
wild-type receptor with respect to recruitment of
-arrestin-2 and internalization, whereas the third
loop mutants R240W, S242A, and T247A showed
the abolishment or reduction of arrestin associa-
tion and a significant reduction of receptor inter-
nalization (14.4%, 29%, and 30.9% vs. 52.4% of
wild type) and serine phosphorylation upon SS28
stimulation. Moreover, we evaluated the ability of
simultaneous mutation of these three residues
(R240, S242, and T247) and C-terminal truncated
receptors to internalize. The progressive trunca-
tion of the C-terminal tail resulted in a progressive
increased internalization (21.6%, 36.7%, and 41%,
respectively) with respect to the full-length total
third-loop mutant (15%). In conclusion, our results
indicate the SST5 third intracellular loop as an im-
portant mediator of -arrestin/receptor interaction
and receptor internalization, whereas they suggest
that residues 328–347 within the C terminus may
play an inhibitory role in receptor internalization.
(Molecular Endocrinology 22: 676–688, 2008)
SOMATOSTATIN (SS) PHYSIOLOGICALLY regu-lates several biological functions, including inhi-
bition of endocrine and exocrine secretion, modulation
of neurotransmission, motor, and cognitive functions,
inhibition of intestinal motility, absorption of nutrient
and ions, and vascular contractility (reviewed in Refs.
1–3). SS is also an important hormonal regulator of cell
proliferation and differentiation (4, 5). These actions
are mediated by a family of five specific G protein-
coupled receptors (GPCRs) termed SST1–5, with im-
portant differences in tissue distribution, coupling to
second messengers, affinity for SS and its analogs,
and intracellular trafficking (1–3). These receptors cou-
ple to Gi/Go proteins and generate a complex series of
intracellular signals, the inhibition of adenylyl cyclase
and the reduction of intracellular cAMP levels being
common to the five receptors.
The high density of SST, in particular SST2 and 5, on
human neuroendocrine tumors has been used clini-
cally to treat patients harboring GH- or TSH-secreting
pituitary adenomas as well as islet cell or carcinoid
tumors with specific SS analogs (6).
A common property of most GPCRs is their ability to
decrease receptor responsiveness in the continued
presence of agonist (7–9). This regulation involves a
coordinated series of events that include phosphory-
lation of the receptor by G protein-coupled receptor
kinases, recruitment of -arrestins, signal termination
(desensitization), and receptor targeting to clathrin-
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coated pits for endocytosis (10). Although the first
identified sites of receptor phosphorylation required
for arrestin binding were localized in the C terminus of
prototypical GPCRs, such as rhodopsin and 2-ad-
renergic receptor, recent studies indicate that relevant
phosphorylation sites can be localized anywhere on
the intracellular surface of the receptor (11–14).
It was previously shown that agonist activation of
SSTs is followed by receptor desensitization and in-
ternalization (15–21). In particular, a previous study
reported that the five rat SSTs transfected in human
embryonic kidney 293 cells differ in their patterns of
-arrestin mobilization and endosomal sorting (22),
SST2A showing stable colocalization with -arrestin in
the same endocytic vescicles, SST3 and SST5 show-
ing transient translocation with -arrestin to the
plasma membrane, and SST1 and SST4 -arrestin
showing independent trafficking.
Because SS is the hypothalamic peptide that phys-
iologically inhibits GH secretion, the aim of this study
was to investigate the molecular determinants medi-
ating the interaction of the human SST5 with -arrestin
and subsequent internalization after stimulation with
SS28, the natural peptide with highest affinity for
SST5, in a pituitary cell line.
RESULTS
Internalization Properties of Wild-Type SST5 in
GH3 Cells
Human SST5 gene expression in GH3 cells was first
characterized by RT-PCR analysis in transfected cells.
Native GH3 cells did not express SST5, whereas GH3
cells transiently transfected with SST5-DsRed2 ex-
pressed SST5 mRNA and protein (data not shown). To
investigate subcellular localization of the expressed
protein, cells were analyzed by fluorescence micros-
copy 48 h after transfection. As shown in Fig. 1A,
SST5-DsRed2 appears to be localized at the plasma
membrane. The functional activity of the wild-type
SST5-DsRed2 receptor was confirmed by examining
its ability to inhibit adenylyl cyclase and reduce intra-
cellular levels of cAMP (51  3% reduction of forsko-
lin-stimulated intracellular cAMP after 30 min incuba-
tion with 100 nM SS28). To study wild-type SST5
internalization after agonist stimulation, GH3 cells
were transiently transfected with SST5-DsRed2 and
incubated in the absence or presence of saturating
concentration of 1 M SS28 (21, 22), the natural pep-
tide with highest affinity for SST5. As shown in Fig. 1A,
in unstimulated cells, wild-type SST5 was clearly vis-
ible at the cell surface. After 30 min incubation the
receptor was localized within intracellular vescicles,
distributed throughout the cytoplasm. The membrane
to intracellular fluorescence ratio (fR) after 30 min of
stimulation resulted in 47.6% of control with a result-
ing internalization of 52.4% in SS28-stimulated cells
with respect to untreated cells (Table 1). The same
results were observed after 60 min of incubation (data
not shown).
GPCR endocytosis commonly occurs via clathrin-
coated pits after ligand activation (25, 26). Hypertonic
sucrose is a commonly used agent that destabilizes
clathrin-coated pits and inhibits clathrin-dependent
endocytosis. To verify the molecular mechanism of
SST5 internalization, transfected cells were preincu-
bated with 0.45 M sucrose for 30 min and then incu-
bated without or with SS28 for 30 min (Fig. 1A). After
this manipulation SST5 remained at the cell membrane
in cells incubated with SS28, with a fR of 89.3% of
control, resulting in 10.7% internalization (Fig. 1B and
Table 1). This result supports the involvement of clath-
rin-coated pits in SS28-mediated SST5 internalization.
SST5 Associates with -Arrestin-2, But Not with
-Arrestin-1, after 5 min of SS28 Stimulation
Arrestins participate in receptor internalization by
binding the components of the endocytotic machinery
of the clathrin-coated pit. To visualize the transloca-
tion of -arrestins to the plasma membrane, we co-
transfected GH3 cells with wild-type SST5 and either
-arrestin-1 or -2 conjugated to EGFP. The results are
presented in Fig. 1C. In the absence of the agonist,
both -arrestin isoforms were uniformly distributed
throughout the cytoplasm. A 5-min SS28 stimulation
induced a rapid redistribution of -arrestin-2 from the
cytoplasm to the cell membrane, where it appears as
punctate fluorescence clusters, whereas no change in
-arrestin-1 distribution was detected. Figure 1D
shows merge imaging indicating a colocalization of
-arrestin-2 with wild-type SST5 after 5 min of agonist
incubation. After 30 min of SS28 exposure, -arres-
tin-2 redistributed to the cytoplasm, whereas endo-
cytic vesicles contained only the receptor.
A biochemical assay was used to confirm colocal-
ization studies and to measure the amount of SST5-
arrestin complexes. GH3 cells cotransfected with wild-
type SST5 and -arrestin-1 or -2, after incubation with
SS28, were treated with dithiobis (succinimidylpropi-
onate) (DSP), a cell-permeable, cleavable cross-link-
ing agent, and SST5 receptors were immunoprecipi-
tated from cell lysates. The cross-linked complexes
were dissociated by incubation of the immunoprecipi-
tates with sodium dodecyl sulfate (SDS) sample buffer
containing reducing agents and analyzed by Western
blotting. The formation of SST5-arrestin complexes
was quantified by detecting the presence of arrestin in
immunoprecipitates. The presence of equal amounts
of receptor was confirmed by reprobing with anti-
SST5 antibody. Figure 1E shows that SS28-induced
-arrestin-2 association was slightly increased above
basal level at 1 min and was maximal at 5 min (2.7-fold
over basal). The complexes were completely dissoci-
ated after 30 min stimulation. No significant change in
-arrestin-1 level after 1 min, 5 min, or 30 min stimu-
lation was observed (data not shown).
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Fig. 1. Effects of SS28 Treatment on the Wild-Type SST5 (Red) Internalization and Arrestin (Green) Mobilization
A, Representative images of GH3 cells transiently transfected with wild-type SST5. Cells were preincubated 48 h after transfection
in the absence or presence of 0.45 M sucrose for 30 min at 37 C and then stimulated with the agonist. The figure shows SST5
distribution in the absence of the agonist and after 30 min of 1 M SS28 incubation. The results shown are representative images of
five individual experiments. B, SST5 internalization was evaluated using ImagePro-Plus 6.0 software. Fluorescence densitymean in two
separate regions corresponding to the plasma membrane and to the cytoplasm was densitometrically determined. Mean membrane
to intracellular fluorescence ratio (fR) was then calculated. For each group, at least 30 cells from three independent transfections were
analyzed by three independent investigators, and the mean value was used for the graph. *, P  0.01 vs. basal. C, Translocation of
-arrestins to the plasma membrane. GH3 cells were transiently cotransfected with wild-type SST5 and either -arrestin-1 or
-arrestin-2. SS28 (1 M) was added to the culture medium for 5 min. Cells were then fixed and examined by fluorescencemicroscopy.
Shown are representative images from one of at least five independent experiments. The figure shows translocation of -arrestin-2 but
not -arrestin-1 to the plasma membrane. D, Internalization of wild-type SST5 and -arrestin-2 trafficking. GH3 cells transiently
cotransfected with SST5-DsRed and -arrestin-2-GFP were incubated with 1 M SS28 for 5 and 30 min. Fixed cells were analyzed by
fluorescence microscopy. The figure shows representative images from one of at least five individual experiments. The figure shows
translocation of -arrestin-2 to the plasma membrane in the middle panel and colocalization of SST5-DsRed with -arrestin-2 in the
right panel. E, Time course of the association of wild-type SST5 with -arrestin-2. GH3 cells transiently cotransfected with wild-type
SST5 and -arrestin-2 were washed and incubated at 37 C with 1 M SS28 for the indicated times before cross-linking. Lysates were
immunoprecipitated (IP) with SST5 antibody, and the presence of -arrestin-2 and SST5 was detected using anti-GFP and anti-SST5
antibody, respectively (upper panel). The figure shows a representative experiment and the analysis of the data obtained from five
separate experiments performed with the image analysis program NIH ImageJ (lower panel). -Arrestin-2 binding is expressed as the
fold increase relative to unstimulated cells and represents mean  SE. *, P  0.05 vs. 0 min. F, Translocation of -arrestin-2 to the
plasma membrane induced by wild-type, unmodified SST5. GH3 cells were transiently cotransfected with wild-type, unmodified SST5
and -arrestin-2-EGFP. SS28 (1 M) was added to the culture medium for 5 min. Cells were then fixed and examined by fluorescence
microscopy. Shown are representative images from one of three independent experiments. The figure shows the redistribution of
-arrestin-2 from the cytoplasm to the cell membrane induced by SS28 stimulation. wt, Wild type.
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These data demonstrated that after SS28 stimula-
tion SST5 associated with -arrestin-2 but not with
-arrestin-1. The cross-linking/coimmunoprecipitation
assay showed that the SST5--arrestin-2 interaction
was transient and the complexes rapidly dissociated.
To verify that DsRed2 protein fused to the C termi-
nus of the receptor did not alter receptor-arrestin in-
teraction, we transiently transfected GH3 cells with
wild-type, unmodified SST5 (23) and -arrestin-2. Flu-
orescence microscopy analysis of -arrestin mobiliza-
tion revealed that 5 min of SS28 stimulation induced
the redistribution of -arrestin-2 from the cytoplasm to
the cell membrane, similarly to that obtained with GH3
cells transfected with the receptor fused to DsRed2
protein (Fig. 1F).
SST5 C-Tail Deletion Mutants Still Internalize and
Associate with -Arrestin-2
For many GPCRs, formation of receptor-arrestin com-
plexes involves phosphorylation of serines and
threonines in the C-terminal tail of the receptor. This
region of SST5 contains 55 residues. Of the three
serines and three threonines present within this region,
NetPhos 2.0 server indicated only Thr361 as a poten-
tial phosphorylation target (score 0.659; threshold
0.5). To identify SST5 structural domains involved in
-arrestin interaction and receptor internalization, we
evaluated the effects of progressive truncations of the
SST5 C-terminal tail (Fig. 2).
Each truncated construct (D347, D338, and D328)
transiently cotransfected in GH3 cells with -arrestin-2
localized at the plasma membrane in the absence of
the agonist (Fig. 3A). The basal expression level at the
plasma membrane of the wild-type and different trun-
cated receptors was similar in transiently transfected
cells, as indicated by Western blot analysis of SST5
immunoprecipitation performed on plasma membrane
cell extracts (Fig. 3B, lower panel). D338 and D328
receptors, but not D347, were partially internalized
upon 5 min of stimulation. A 30-min agonist exposure
induced evident internalization of D338 and D328,
whereas the truncation at position 347 attenuated re-
ceptor internalization (Fig. 3A). As shown in Fig. 3B, 30
min of SS28 stimulation induced a progressive reduc-
tion of fR that corresponded to progressive deletions
(Table 1). Internalization of D328 mutant (58.4%) was
significantly increased (P  0.02) with respect to wild-
type SST5 (52.4%), suggesting that a short or absent
C-terminal tail could enhance the internalization
process.
Fluorescence microscopy analysis of -arrestin mo-
bilization revealed that, after 5 min of SS28 stimula-
tion, the truncation mutants induced a translocation of
-arrestin-2 to the plasma membrane where it colo-
calized with the receptors (Fig. 3A).
Cross-linking/coimmunoprecipitation assay (Fig.
3C) showed that the amount of -arrestin-2 coimmu-
noprecipitated with D328 receptor was slightly in-
creased at 1 min and was considerably increased
above basal levels at 5 min of stimulation (2.69-fold
over basal). No association of -arrestin-1 to D328
SST5 was detected (data not shown).
SST5 Third Loop Mutants Are Associated with
Reduced Internalization and Phosphorylation
after SS28 Stimulation
To identify a region of SST5 that mediates agonist-
induced internalization, we focused our studies on the
third intracellular loop, which contains two predicted
sites of phosphorylation (Ser242, P  0.994; and
Thr247, P  0.461). The presence of a glutamic acid
residue (Glu243) in close proximity is predicted to
enhance their phosphorylation by a G protein-coupled
receptor kinase (7) and to increase the affinity for
-arrestin. We created three-point mutant receptors
by site-directed mutagenesis in which these three res-
Table 1. Quantitative Analysis of Internalization of Wild-Type and Mutated SST5 Receptor
FR 0 min FR 30 min % FR % Internalization P
Wild type 1.577  0.391 0.750  0.163 47.56 52.44
Wild type  sucrose 1.487  0.257 1.328  0.315 89.30 10.70 0.0000a
D347 1.510  0.365 0.900  0.212 59.62 40.38 0.0414a
D338 1.316  0.210 0.685  0.171 52.06 47.94 0.3231a
D328 1.392  0.290 0.579  0.187 41.63 58.37 0.0204a
S242A 1.463  0.185 1.039  0.171 71.01 28.99 0.0001a
E243A 1.322  0.156 0.764  0.222 57.80 42.20 0.0574a
T247A 1.452  0.147 1.003  0.202 69.07 30.93 0.0046a
R240W 1.403  0.169 1.201  0.210 85.60 14.40 0.0000a
RST 1.414  0.224 1.202  0.206 85.01 14.99 0.0000a
RST-347 1.386  0.182 1.087  0.182 78.43 21.57 0.0348b
RST-338 1.413  0.207 0.895  0.257 63.32 36.68 0.0306b
RST-328 1.344  0.132 0.792  0.067 58.97 41.03 0.0013b
Percent of receptor internalization was calculated from the stimulated to basal fluorescence ratio (fR). For each group, at least 30
cells from three independent transfections were analyzed by three independent investigators, and the mean value was used for
the graphs.
a P vs. wt; b P vs. correspondent deleted mutant.
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idues were replaced by Ala (S242A, E243A, and T247A
mutants). We also tested a naturally occurring SST5
third loop mutant (R240W) previously found in one
acromegalic patient resistant to SS analogs (23). As
shown in Fig. 4, A and B, mutant receptors were
correctly targeted to the plasma membrane. Average
data from multiple experiments in which the internal-
ization was quantified are shown in Table 1 and Fig.
4B. The mutation of Ser242 or Thr247 to Ala strongly
reduced SST5 internalization (29.0% and 30.9%, re-
spectively, with respect to 52.4% of wild type),
whereas E243A mutant showed lower (42.2%), but not
significant (P  0.057), internalization with respect to
wild-type SST5 after 30 min of agonist incubation.
Both mutation of Arg240 to Trp and the simultaneous
mutation of R240, S242, and T247 in the total third-
loop mutant [R240, S242, and T247 (RST)] almost
completely abolished internalization (14.4% and
15.0%, respectively). To exclude differences in the
level of expression at the plasma membrane, we per-
formed immunoprecipitation followed by Western blot
analysis on plasma membrane cell extracts. Western
blots showed comparable expression levels of the wild
type and different mutated receptors at the cell sur-
face (Fig. 4B, lower panel).
By fluorescence microscopy, no -arrestin translo-
cation to RST, R240W, S242A, T247A, and E243A
SST5 was observed after 5 min of SS28 incubation
(Fig. 4A).
To measure the arrestin association by the cross-
linking/coimmunoprecipitation assay, transfected
cells were stimulated with SS28 for 5 min followed by
DSP cross-linking, immunoprecipitation, and Western
blotting (Fig. 4C). When we transfected cells with RST
SST5 and -arrestin-2, the amount of arrestin in the
immunoprecipitates after 5 min of stimulation was 1.5-
fold over basal, suggesting a strongly reduced arrestin
association for the RST mutant with respect to wild-
type SST5 (2.7-fold over basal). Reduced arrestin as-
sociation was also observed with S242A, T247A, and
R240W mutants (Fig. 4, C and D).
Fig. 2. Schematic Representation of Wild-Type and Mutant SST5 Receptors
The third intracellular loop (A) and the C-terminal domain (B) are shown in detail to illustrate the structure of the different mutant
receptors that were constructed. A, Residues in the third intracellular loop mutated to Ala (Ser242, Glu243, and Thr247) and
residue Arg240 mutated to Trp are highlighted in black. B, The figure shows progressive deletions of the C-terminal tail introduced
by PCR to create truncated receptors with variable length C-tail (D347, D338, and D328). Potential phosphorylation sites (Ser and
Thr residues) in the C-terminal domain are highlighted in black. Of these, NetPhos 2.0 server indicated only Thr361 as a potential
phosphorylation target (score  0.659; threshold  0.5). C, Schematic representation of the model proposed for SST5 arrestin
binding and internalization. Under basal conditions, C-terminal tail of wild-type SST5 is associated with the third cytoplasmic loop.
SS28 binding promotes receptor activation and phosphorylation of residues within the third cytoplasmic loop, allowing these two
domains to disassociate and arrestin to bind to the receptor. Arrestin binding targets the receptor to clathrin-coated pits for
endocytosis. wt, Wild type. The P within a circle indicates receptor phosphorylation.
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To test whether mutation of the RST motif affects
the phosphorylation of SST5, GH3 cells transiently
transfected with wild-type or mutated SST5 were in-
cubated with 1 M SS28 for 5 min. SST5 was immu-
noprecipitated from cell lysates, and Western blot
analysis was performed using antiphosphoserine or
antiphosphothreonine antibodies. Loading of equal
amounts of receptor proteins in each lane was con-
firmed with anti-SST5 antibody. The level of SST5
serine phosphorylation after 5 min of SS28 stimulation
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Fig. 3. Internalization Properties and Arrestin Binding of SST5 Deletion Mutants
A, Internalization of progressive deleted SST5 mutants and -arrestin-2 trafficking. GH3 cells cotransfected with -arrestin-2
and SST5 with progressive deletions of the C-terminal tail were incubated with 1 M SS28 for 5 and 30 min. Fixed cells were
analyzed by fluorescence microscopy. Representative images from one of at least five individual experiments are shown. Each
truncated construct (D347, D338, and D328) transiently cotransfected in GH3 cells with -arrestin-2 localized at the plasma
membrane in the absence of the agonist. The figures show translocation of -arrestin-2 to the plasma membrane at 5 min of SS28
stimulation (“-arr-2” panel) and colocalization of SST5 with -arrestin-2 (“merge” panel). A 30-min agonist exposure induced
evident internalization of D338 and D328 whereas the truncation at position 347 attenuated receptor internalization. B, Internal-
ization of SST5-truncated mutants was evaluated using ImagePro-Plus 6.0 software. SS28 stimulation for 30 min induced a
progressive reduction of fR that corresponded to progressive deletions. Meanmembrane to intracellular fluorescence ratio (fR) was
calculated. For each group, at least 30 cells from three independent transfections were analyzed, and the mean value was used
for the graph. §, P  0.05 vs. wild-type SST5  SS28 30. *, P  0.01 vs. basal. The lower panel shows a representative Western
blot of wild-type and deleted SST5 immunoprecipitated from cell membrane extracts of transiently transfected cells in basal
conditions. C, Time course of the association of D328 SST5 with -arrestin-2. GH3 cells transiently cotransfected with D328 SST5
and -arrestin-2 were washed and incubated at 37 C with 1 M SS28 for the indicated times before cross-linking. Lysates were
immunoprecipitated (IP) with SST5 antibody, and the presence of -arrestin-2 and SST5 was detected using anti-GFP and
anti-SST5 antibody, respectively (upper panel). Representative images from at least five individual experiments are shown. The
analysis of the data was performed with the image analysis program NIH ImageJ (lower panel). -Arrestin-2 binding is expressed
as the fold increase relative to unstimulated cells and represents mean  SE. *, P  0.05 vs. 0 min. arr2, Arrestin-2; wt, wild type.
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Fig. 4. Effects of Introducing Mutations within the Third Cytoplasmic Loop of SST5 (Red) on -Arrestin-2 (Green) Translocation
and Receptor Internalization
A, GH3 cells transiently cotransfected with -arrestin-2 and SST5 with simultaneous mutations of R240, S242, and T247 (RST) were
incubated with SS28 1 M for 5 and 30 min. We created three-point mutant receptors by site-directed mutagenesis in which these three
residues were replaced by Ala (S242A, E243A, and T247A mutants). We also tested a naturally occurring SST5 third-loop mutant (R240W)
previously found in one acromegalic patient resistant to SS analogs. As shown here for RST mutant as a representative example, mutant
receptors were correctly targeted to the plasma membrane. No -arrestin translocation was observed after 5 min SS28 incubation and,
accordingly, RSTmutant internalization was almost completely abolished. Fixed cells were analyzed by fluorescencemicroscopy. The figure
shows representative images from one of at least five individual experiments. B, SST5 third-loop mutants (R240W, S242A, T247A, E243A,
and RST) internalization was evaluated using ImagePro-Plus 6.0 software. Mean membrane to intracellular fluorescence ratio (fR) was
calculated. For each group, at least 30 cells from three independent transfectionswere analyzed and themean valuewas used for the graph.
*, P  0.01 vs. basal; §, P  0.01 vs. wild-type SST5  SS28 30. The lower panel shows a representative Western blot of wild-type and
third-loopmutatedSST5 receptors immunoprecipitated fromcell membrane extract in basal conditions. C, Association of third-loopmutants
SST5 with -arrestin-2. GH3 cells transiently cotransfected with wild-type, RST, S242A, T247A, or R240W SST5 and -arrestin-2 were
washed and incubated at 37Cwith 1MSS28 for 5min before cross-linking. Lysateswere immunoprecipitated (IP) with SST5 antibody, and
the presence of-arrestin-2 andSST5was detected using anti-GFP and anti-SST5 antibody, respectively. The figure shows a representative
experiment. D, The figure compares the association of -arrestin-2 to wild-type, third loop-mutated, and D328-deleted SST5 receptors. The
analysis of the data obtained from five separate experiments was performed with the image analysis program NIH ImageJ. -Arrestin-2
binding is expressed as the fold increase relative to unstimulated cells and represents mean  SE. *, P  0.05 vs. wild type. E, Analysis of
wild-type and mutated SST5 phosphorylation. GH3 cells transiently transfected with wild type or mutated SST5 were incubated with SS28
1M for 5min. SST5was immunoprecipitated from cell lysates, andWestern blot analysis was performed using antiphosphoserine antibody
(lower panel). Loading of equal amounts of receptor proteins in each lane was confirmed with anti-SST5 antibody. The upper panel shows
the analysis of the data obtained from five separate experiments performed with the image analysis program NIH ImageJ and represents
mean SE. *,P 0.05 vs. basal. The level of agonist-induced serine phosphorylation, expressed as the fold increase relative to unstimulated
cells, was reduced for RST (1.15-fold over basal), S242A (0.93-fold over basal), and R240W (1.38-fold over basal) receptor with respect to
wild-type SST5 (1.93-fold over basal). F, Autoradiogram of SDS-PAGE analysis of immunoprecipitates from whole-cell phosphorylation
assays. GH3 cells were transiently transfected with the appropriate plasmids for 48 h, labeled with [32P]orthophosphate, and incubated with
1 M SS28 for 5 min. SST5 was immunoprecipitated, and the samples were subjected to SDS-PAGE followed by autoradiography. A
representative experiment is shown. arr-2, arrestin-2; wt, wild type; P-Ser, phosphoserine.
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was reduced for RST, S242A, and R240W mutant
receptors with respect to wild type (Fig. 4E). No sig-
nificant difference of threonine phosphorylation was
measured after agonist stimulation of SST5 in the
presence or absence of mutations. These data sug-
gest that, in our system, the residue Ser242, but not
Thr247, is a target for phosphorylation. To further con-
firm these results, we measured the incorporation of
radioactive phosphate by whole-cell phosphorylation
assay (Fig. 4F). We observed a marked increase in
phosphorylation of wild-type SST5 after incubation
with SS28, whereas in cells expressing RST, S242A,
and R240W mutant receptors agonist-induced recep-
tor phosphorylation was reduced with respect to wild
type.
Third-Loop Mutated and C-Tail-Deleted SST5
To determine whether mutations of the third loop
would reduce internalization if these mutations were
created within the context of the truncated constructs,
we evaluated the ability of the total third-loop mutant
(RST) and C-terminal truncated receptors to internal-
ize. As shown in Table 1 and Fig. 5, A and B, progres-
sive truncation of the C-terminal tail resulted in a pro-
gressive increased internalization (21.6%, 36.7%, and
41.0%, respectively) with respect to full-length RST
mutant, which however remained reduced with re-
spect to wild-type or deleted receptor.
Biochemical Analysis of SST5 Endocytosis Using
Cleavable Biotin
To confirm SST5 internalization data, a highly sensitive
biochemical assay based upon cleavable biotin was
used. SST5 receptors on the cell surface were biotin-
ylated with a cleavable reagent. After SS28 stimula-
tion, glutathione, a membrane-impermeant reducing
agent, was used to cleave biotin of cell surface pro-
teins, whereas internalized receptors were inaccessi-
ble to glutathione (28). As shown in Fig. 6A, by this
approach we demonstrated that 1 M SS28 induces
47.8% internalization of wild-type SST5 after 30 min of
stimulation, whereas only 14.9% of the surface pop-
ulation of RST receptors was internalized in the same
conditions. The amount of internalized, glutathione-
resistant D347, D338, and D328 SST5 was, respec-
tively, 42.3%, 52.7% and 63.8%. These results are in
complete agreement with the data obtained with flu-
orescence microscopy (Fig. 6B).
DISCUSSION
In the present study, we characterized the structural
domains of human SST5 involved in internalization
and -arrestin recruitment processes in a pituitary
model, using both biochemical and fluorescence mi-
croscopy approaches, and demonstrated that the
third intracellular loop is crucial for agonist-dependent
receptor internalization and -arrestin interaction. As
demonstrated in other cell systems (15–21), wild-type
SST5 functionally expressed at the plasma membrane
in GH3 cells efficiently internalized upon the stimula-
tion with SS28, the natural peptide with highest affinity
for SST5 (52.4% internalization). Moreover, SST5 in-
ternalization was inhibited by hypertonic sucrose, a
classical inhibitor of clathrin-mediated endocytosis,
demonstrating that SST5 trafficking and signaling are
regulated by clathrin-dependent pathways. We also
observed that SS28 induced the recruitment of -ar-
restin-2, but not -arrestin-1, to the plasmamembrane
where it colocalized with SST5. The arrestin-receptor
complexes dissociated at or near the cell membrane
and, after prolonged agonist exposure, SST5 internal-
ized in endocytotic vesicles, whereas arrestin redis-
tributed in the cytoplasm. The molecular mechanism
of arrestin-receptor interaction is based on the pres-
ence of two sensor sites within the arrestin protein: an
activation sensor that binds receptor elements that
change conformation upon activation, and a phos-
phate sensor that binds receptor-attached phos-
phates or negatively charged residues, independently
from the sequence context (29). Because, for most
GPCRs, the first phosphorylation sites relevant for ar-
restin binding are localized either in the C terminus or
the third intracellular loop, we concentrated on these
two regions to define SST5 structural domains in-
volved in receptor internalization and binding to -ar-
restin-2. Using a series of C-terminal tail-truncated
receptors, we demonstrated that a short or absent
C-terminal tail did not reduce, but even enhanced, the
internalization process. In fact, the deleted mutants,
D347, D338, and D328, retained the ability to interact
with -arrestin and to internalize. Moreover, internal-
ization efficiency increased with the length of the de-
leted region. Indeed, the mutant with the shorter C-tail,
i.e. D328 mutant, internalized more efficiently than the
wild-type receptor, suggesting that residues 328–347
within the SST5 C terminus play an inhibitory role in
receptor internalization, as previously shown for a very
small subset of GPCRs (11, 14, 30). Conversely, the
observation that the D347 mutant showed reduced
internalization with respect to full-length SST5 sug-
gests that the segment corresponding to amino acids
347–364 contains positive molecular signals for inter-
nalization. Interestingly, deletion of the last 17 residues
occurring in D347 mutant abolished the only phos-
phorylation site (threonine 361) predicted by NetPhos
2.0 server.
These data are in contrast with the only study on
SST5 structure-function relationship available in the
literature (16). In fact, it has been previously re-
ported that the C-tail was critical for SST5 internal-
ization, coupling with adenylyl cyclase and desen-
sitization in Chinese hamster ovary K1 cells (16).
Admittedly, the different cellular host system used
for receptor expression might account for the differ-
ent results. Furthermore, because in that study in-
Peverelli et al. • Mechanisms of Human SST5 Internalization Mol Endocrinol, March 2008, 22(3):676–688 683
D
ow
nloaded from
 https://academ
ic.oup.com
/m
end/article-abstract/22/3/676/2661299 by guest on 25 April 2019
ternalization was investigated by measuring radioli-
gand, the results might reflect trafficking and
processing of the radioligand but not of the receptor
itself.
To identify third-loop residues involved in arrestin
interaction, we created three-point mutant recep-
tors in which serines, threonines, or acidic residues
were replaced by Ala (S242A, E243A, and T247A).
We also tested a naturally occurring SST5 third-loop
mutant (R240W) previously detected in our labora-
tory in one acromegalic patient resistant to SS an-
alogs (23). No -arrestin translocation (by fluores-
cence microscopy) or a strongly reduced arrestin
association (by cross-linking-coimmunoprecipita-
tion assay) were detectable after SS28 stimulation of
S242A, T247A, and R240W, whereas E243A partially
retained the ability to associate with arrestin. Ac-
cordingly, the E243A mutant showed slightly lower
internalization, suggesting that the role of this acidic
residue is not crucial for arrestin binding. By con-
trast, Ser242 mutation to Ala caused a significant
decrease in receptor internalization (29.0% with re-
A
0,0
0,5
1,0
1,5
2,0
2,5
wt RST RST-347 RST-338 RST-328
*
Basal
SS28 30’
§
§
*
*
*
B
 RST-328 SST5        β-arr-2             merge
5’
0’
30’
Fig. 5. Determination Whether Mutations Would Reduce Internalization
To determine whether mutations of the third loop would reduce internalization if these mutations were created within the
context of the truncated constructs, we evaluated the ability of SST5 with simultaneous mutations of RST and C-terminal
truncated receptors to internalize. A, GH3 cells transiently cotransfected with -arrestin-2 and C-terminal tail truncation (D328)
on third loop-mutated RST SST5 were incubated with 1 M SS28 for 5 and 30 min. Fixed cells were analyzed by fluorescence
microscopy. The figure shows representative images from one of at least five individual experiments. B, Effect of C-terminal tail
truncations on third loop-mutated RST-SST5 internalization. The figure shows that progressive truncation of the C-terminal tail
resulted in a progressive increased internalization with respect to full-length RST mutant, which, however, remained reduced with
respect to wild-type or deleted receptor. Quantitative analysis was performed by ImagePro-Plus 6.0 software. For each group,
at least 30 cells from three independent transfections were analyzed, and the mean value was used for the graph. *, P  0.01 vs.
basal; §, P  0.01 vs. wild type SST5  SS28 30. arr-2, Arrestin-2; wt, wild type.
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spect to 52.4% of wild type), indicating that the
phosphorylation of this residue is essential to acti-
vate arrestin phosphate sensor. This hypothesis has
been further confirmed by the finding of reduced
phosphorylation of the RST, R240W, and S242A
mutants by immunoprecipitation experiments using
antiphosphoserine antibody and whole-cell phos-
phorylation assay. Surprisingly, R240W mutant
showed a dramatic loss of internalization (14.4%)
that was comparable with that observed with the
simultaneous mutation of the three residues, Arg,
Ser, and Thr, within the third loop (RST). Although
mutation of Arg240 to Trp is predicted by NetPhos
2.0 server to abolish Ser242 phosphorylation, to
explain the more dramatic reduction of internaliza-
tion induced by this mutant in comparison with
Ser242 mutation, we hypothesize that Arg240 resi-
due, highly conserved in all five SS subtypes, might
also be directly involved in receptor binding by the
activation sensor of arrestin. The location of the
regions that bind arrestin activation sensor has not
been fully characterized in any GPCR. However,
numerous studies indicate that arrestins can bind in
vitro to specific GPCR fragments located within the
third intracellular loop, which do not become phos-
phorylated upon agonist activation (31, 32).
Our data suggest a model for SST5 internalization
comparable with that hypothesized for dopamine D1
receptor (Fig. 1) (11). Under basal conditions, the C
terminus of D1 is in close association with the third
cytoplasmic loop. Receptor activation promotes a se-
quential phosphorylation of residues, first on the C-
terminal tail and then within the third cytoplasmic loop,
allowing these two domains to disassociate and ar-
restin to bind to the activated third loop. Our results
indicate that the third intracellular loop of wild-type
SST5 relieves an intrinsic inhibitory effect of the C-
terminal tail on arrestin binding and receptor internal-
ization. Accordingly, these processes are facilitated by
the truncation of the C-terminal tail as indicated by the
observation that D328 mutant internalized more effi-
ciently than wild-type SST5. If the third loop is dam-
aged (R240W, S242A, and T247A mutants), the inter-
action of this region with -arrestin might be sterically
prevented by the C terminus. To test whether the role
of the third intracellular loop is to remove the C-tail or
to directly bind arrestin, we evaluated the effect of
multiple third-loop mutations (RST) within the context
of the truncated constructs. In the absence of the
C-terminal domain, the mutated receptor showed an
increased internalization (41.0%) with respect to full-
length RST mutant (15.0%), suggesting that the third
cytoplasmic loop of SST5 is essential to remove the
C-tail inhibition.
In conclusion, our results indicate SST5 third intra-
cellular loop as a crucial mediator of -arrestin binding
and receptor internalization, whereas they suggest
that residues 328–347 within the C terminus may play
an inhibitory role in receptor internalization. Whether
the first and second intracellular loops are also in-
volved in -arrestin interaction remains to be
investigated.
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Fig. 6. Effect of Third-Loop Mutations and Progressive C-
Terminal Tail Truncation on SST5 Internalization
SST5 internalization was evaluated either by fluorescence
microscopy and biochemical assay. A, Internalization of wild-
type and mutated receptor was determined biochemically
using cell surface biotinylation assay. The upper panel shows
a representative experiment. Lane 1 (total) shows the total
amount of SST5 receptor biotinylated at the cell surface; lane
2 (strip) indicates the efficiency of biotin cleavage by glutha-
tione from SST5 receptors present in the plasma membrane.
Internalized receptors were detected by their resistance to
biotin cleavage after incubation of biotinylated cells with 1 M
SS28 for 30 min at 37 C. The analysis of the data obtained
from five separate experiments was performed with the im-
age analysis program NIH ImageJ (lower panel). Receptor
internalization was expressed as a percentage relative to the
total amount of biotinylated receptor present without cleav-
age, and the mean value (SE) was used for the graph. *, P 
0.05 vs. wild type. B, The figure shows the summary of %
internalization of wild-type compared with mutated SST5
receptors, by fluorescence microscopy. Images of GH3 cells
transiently cotrasfected with -arrestin-2 and SST5 were pro-
cessed using Image ProPlus 6.0 software, and the amount of
internalized receptor after agonist stimulation was analyzed
in single cells. Percent of receptor internalization was calcu-
lated from the stimulated (30 min; 1 M SS28) to basal fR ratio.
*, P  0.05 vs. wt; §, P  0.05 vs. correspondent deleted
mutant. wt, Wild type.
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MATERIALS AND METHODS
Materials
GH3 cells (ATCC CCL-82.1) were purchased from American
Type Culture Collection (Manassas, VA). Ham F10 medium,
fetal calf serum, L-glutamine, penicillin, streptomycin, T4 DNA
ligase, and AccuPrime proofreading polymerase were from
Invitrogen (Carlsbad, CA). Restriction enzymes were from
New England Biolabs (Beverly, MA). Transfection reagent Jet
PEI was from Polyplus Transfection (San Marcos, CA). The
plasmid encoding -arrestin-1-EGFP and pDsRed2-N1 ex-
pression vector were kindly provided by Dr. Bodduluri
Haribabu (University of Louisville Health Sciences, Louisville,
KY). FluoSave mounting medium was from Calbiochem (San
Diego, CA). SS28, sucrose, paraformaldehyde, and antiphos-
phoserine antibody were from Sigma-Aldrich (St. Louis, MO).
Protein A/G Plus-Agarose, anti-SST5 (H-54) and antiphos-
phothreonine antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Antibiotin, horseradish
peroxidase-linked antibody was from Cell Signaling Technol-
ogy (Danvers, MA). DSP and Sulfo-NHS-SS-Biotin were from
Pierce Chemical Co. (Rockford, IL).
Plasmids and Constructs
To generate the wild-type (full-length and truncated) and the
mutated forms, human wild-type SST5 cDNA was amplified
starting from the previous cassette construct DNA as tem-
plate (23) and subcloned into AgeI/HindIII multiple cloning
site of pDsRed2-N1 expression vector. Point mutations were
introduced into SST5 by PCR-based mutagenesis replacing
serine 242, glutamic acid 243, and threonine 247 with alanine
(Fig. 2). The naturally occurring mutant R240W was amplified
starting from the previous cassette construct DNA as previ-
ously reported (23). A total third-loop mutant (RST) was cre-
ated by replacing serine 242 and theonine 247 with alanine
using R240W mutant as a template. Progressive deletion
mutants of the SST5 C-terminal tail were created by PCR
using wild-type or mutated SST5 as templates (Fig. 2). To
construct fusions to the N terminus of DsRed2, the target
genes were cloned into pDsRed2-N1 in frame with the
DsRed2 coding sequence, with no intervening in-frame stop
codons. Human -arrestin-2 cDNA was amplified by RT-PCR
using human pituitary mRNA as a template and subcloned
into the SacI/SalI multiple cloning site of the expression vec-
tor encoding -arrestin-1-EGFP. Primers were designed to
avoid changes in the reading frame, with no intervening in-
frame stop codons, to construct fusion to the N terminus of
EGFP. The primers used for the construction of different
mutant and wild-type receptors and -arrestin-2 are shown in
Table 2. The sequence of all constructs was verified by
dideoxynucleotide sequencing.
Cell Culture and Transfection
Rat pituitary GH3 cells were grown in Ham’s F10 medium
supplemented with 10% fetal calf serum, 2 mM glutamine,
100 U/ml penicillin, and 100 g/ml streptomycin at 37 C in a
humidified atmosphere of 95% air-5% CO2. Chinese hamster
ovary K1 cells were cultured in MEM containing 10% fetal
calf serum at 37 C in a humidified atmosphere of 95% air-5%
CO2. Transient transfections of -arrestin and SST5 were
performed using JetPEI according to the instruction of the
manufacturer. Western blot analysis was performed to con-
trol the expression level of SST5-DsRed2 in transiently trans-
fected cells. Immunoblotting was performed using a 1:1000
dilution of the SST5(H-54) antibody and revealed by a chemi-
luminescent detection system.
To confirm the functional activity of the wild-type SST5-
DsRed2 receptor, intracellular cAMP was measured by en-
zymatic immunoassay (Amersham Pharmacia Biotech, Pis-
cataway, NJ) as previously reported (23).
Fluorescence Microscopy
GH3 cells were transiently cotransfected with -arrestin-
EGFP and SST5-DsRed2. Cells were treated 48 h after trans-
fection with saturating concentration of SS28 (1 M) for the
indicated times, fixed with 4% paraformaldehyde for 20 min
at room temperature, and washed several times in PBS.
Coverslips were mounted on glass slides with FluoSave
mounting medium for fluorescence microscopy examination.
All images were collected using Leica DM IRE 2 (Leica Corp.,
Deerfield, IL) and processed with Image ProPlus 6.0 software.
Quantitation of Internalization
SST5 internalization was evaluated either by fluorescence
microscopy and biochemical analysis. Images of GH3 cells
transiently cotransfected with -arrestin and SST5 were pro-
cessed using Image ProPlus 6.0 software. The amount of
internalized receptor after agonist stimulation was analyzed
in single cells. The fluorescence density mean (F) in two
Table 2. Oligonucleotide Primers Used in the Creation of Wild-Type SST5, C-Tail Deletion Mutants, Third Loop Mutants, and
-Arrestin-2
Oligo Sequence (5–3)
SST5 forward TGTATAAGCTTGCCATGGAGCCCCTGTTCC
SST5 reverse GCCTAACCGGTGCCAGCTTGCTGGTCTGCA
D347 reverse CGCATACCGGTGCCGTGGCCTCCTGCTGCT
D338 reverse CCGATACCGGTGCGTCTGGACGCGGCTCCG
D328 reverse GCGATACCGGTGCCTTGGCACCAGAGCCCT
S242A junction forward CTGCGTGCGGCGGCGCGCGGAGCGGAAGGTGAC
S242A junction reverse GTCACCTTCCGCTCCGCGCGCCGCCGCACGCAG
E243A junction forward TGCGGCGGCGCTCGGCGCGGAAGGTGACGCG
E243A junction reverse CGCGTCACCTTCCGCGCCGAGCGCCGCCGCA
T247A junction forward CGGAGCGGAAGGTGGCGCGCATGGTGTTG
T247A junction reverse CAAGACCATGCGCGCCACCTTCCGCTCCG
R240W/S242A junction forward TGCGTGCGGTGGCGCGCGGAGCGGAAGGTG
R240W/S242A junction reverse CACCTTCCGCGCCGCGCGCCACCGCACGCA
BARR2 forward TGTATGAGCTCGCCATGGGGGAGAAACCCG
BARR2 reverse TGTATGTCGACGCCGCAGAGTTGATCATCA
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separate regions corresponding to the plasma membrane
and to the entire intracellular area were densitometrically
determined. Mean membrane to intracellular fluorescence
ratio (fR) was then calculated according to the following
equation:
fR  [F(membrane)  F(background)]/[F(citosol) 
F(background)]
For each group, at least 30 cells from three independent
transfections were analyzed by three independent investiga-
tors, and the mean value was used for the graphs.
Biochemical analysis of receptor endocytosis was per-
formed using the cleavable biotin method (28). Transiently
transfected GH3 cells were washed three times with ice-cold
PBS, and the cell surface was biotinylated with 500 g/ml
cleavable sulfo-NHS-S-S-biotin for 30 min at 4 C. Unreacted
biotin was quenched and removed by three washes with cold
Tris-buffered saline-10 mM glycine. Biotinylated cells were
incubated in prewarmed medium with or without SS28 1 M
at 37 C for 30 min, and then cells were chilled on ice to stop
endocytosis. To release the biotin label from proteins at the
cell surface, cells were washed twice with cold glutathione
strip buffer (50 mM glutathione, 75 mM NaCl, 75 mM NaOH,
10% fetal bovine serum in H2O) at 4 C for 20 min. Excess
glutathione was then quenched for 30 min at 4 C in iodoac-
etamide buffer (50 mM iodoacetamide; 1% BSA; in PBS, pH
7.4). Cells were lysed with 0.5 ml lysis buffer in the presence
of protease inhibitors.
For immunoprecipitation, 60 g of total cellular protein was
incubated with 2 g of SST5(H-54) antibody for 1 h at 4 C.
The resuspended volume of protein A/G Plus-Agarose (20 l)
was then added, and tubes were incubated for 90 min at 4 C
on a rotating device. The pellet was washed with PBS with
0.05% BSA and PBS, and resuspended in 30 l of PBS with
0.1% SDS for elution. Eluted proteins were resolved by SDS-
PAGE under reducing or nonreducing conditions and trans-
ferred to a nitrocellulose filter. To detect biotinylated proteins,
1:500 dilution of antibiotin, horseradish peroxidase-linked an-
tibody was used. The presence of equal amounts of receptor
in the immunoprecipitates was confirmed by stripping and
reprobing with anti-SST5 antibody (1:2000) and antirabbit
secondary antibody covalently coupled to horseradish per-
oxidase (1:2000). The resulting bands were evaluated with
the image analysis program NIH ImageJ. Experiments were
repeated at least five times.
Quantitation of SST5-Arrestin Interaction
The immunoprecipitation method was modified to include a
cross-linking step as recently described (33, 34) for coimmu-
noprecipitation of SST5 and -arrestin. GH3 cells transiently
cotransfected with SST5 and -arrestin were washed three
times with 0.15 M NaCl, 20 mM HEPES, pH 7.4, and incubated
with or without 1 M SS28 at 37 C for the indicated times. At
the end of this incubation, 2 mM solution of DSP was added,
and the cells were incubated 30 min at room temperature,
washed with PBS containing 50 mM Tris-HCl (pH 7.4), and
lysed in 0.5 ml lysis buffer. Total cellular protein (100 g) was
incubated with 2 g of SST5(H-54) antibody, and immuno-
precipitation of SST5 was performed as described above.
The cross-linked complexes were dissociated by incubation
of the immunoprecipitates with SDS sample buffer containing
reducing agents and analyzed by Western blotting. -Arrestin
was visualized with anti-GFP (green fluorescent protein) an-
tibody (1:1000) and antimouse secondary antibody co-
valently coupled to horseradish peroxidase. The presence of
equal amounts of receptor in the immunoprecipitates was
confirmed by stripping and reprobing with anti-SST5 anti-
body (1:2000). The amount of arrestin expressed was deter-
mined using 30 g of the whole-cell lysate containing equiv-
alent amounts of protein.
Analysis of Protein Phosphorylation
The phosphorylation sites in wild-type and mutant SST5 were
predicted using NetPhos 2.0 Server (http://www.cbs.dtu.dk/
services/NetPhos/). The NetPhos 2.0 server produces neural
network predictions for serine, threonine, and tyrosine phos-
phorylation sites in eukaryotic proteins (24).
For the phosphorylation assay, GH3 cells were transiently
transfected with wild-type or mutated SST5 for 48 h, incu-
bated with 1 M SS28 for the indicated times, and lysed with
0.5 ml lysis buffer in the presence of protease inhibitors.
SST5 was immunoprecipitated with 2 g of SST5 antibody as
described above.
Western blot analysis was performed using antiphospho-
serine (1:800) and antiphospho-threonine antibody (1:400),
and loading of equal amounts of receptor proteins in each
lane was confirmed by reprobing with anti-SST5 antibody
(1:2000).
To further confirm these results, we performed a whole-cell
phosphorylation assay (27). GH3 cells were transiently trans-
fected with the appropriate plasmids for 48 h, washed with
serum- and phosphate-free medium, and then labeled with
200 Ci/ml carrier-free [32P]orthophosphate for 60 min at 37
C. Labeled cells were incubated with 1 M SS28 for 5 min,
washed with ice-cold PBS, and lysed with radioimmune pre-
cipitation buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 5 mM
EDTA; 10 mM NaF; 10 mM disodium pyrophosphate; 1%
Nonidet P40; 0.5% sodium deoxycholate; 0.1% SDS; 0.2 mM
phenylmethylsulfonylfluoride; 10 g/ml leupeptin; 1 g/ml
pepstatin A; 1 g/ml aprotinin; and 10 g/ml bacitracin).
SST5 was immunoprecipitated with 2 g of SST5 antibody as
described above. The samples were subjected to SDS-PAGE
followed by autoradiography. Loading of equal amounts of
receptor proteins in each lane was confirmed by Western blot
analysis.
Statistical Analysis
The results are expressed as the mean  SD. A paired two-
tailed Student’s t test was used to detect the significance
between two series of data. P  0.05 was accepted as
statistically significant.
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